ArticlePloS one2013

Suppression of natural killer cells by sorafenib contributes to prometastatic effects in hepatocellular carcinoma.

Qiang-Bo Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.